Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS

(DGX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/22/2021 02/23/2021 02/24/2021 02/25/2021 02/26/2021 Date
116.21(c) 117.49(c) 115.74(c) 114.63(c) 115.59(c) Last
2 180 379 1 464 446 993 684 1 434 481 1 513 691 Volume
-2.53% +1.10% -1.49% -0.96% +0.84% Change
More quotes
Financials (USD)
Sales 2021 9 552 M - -
Net income 2021 1 339 M - -
Net Debt 2021 3 103 M - -
P/E ratio 2021 11,8x
Yield 2021 2,06%
Sales 2022 8 215 M - -
Net income 2022 903 M - -
Net Debt 2022 3 224 M - -
P/E ratio 2022 17,0x
Yield 2022 2,20%
Capitalization 15 426 M 15 426 M -
EV / Sales 2021 1,94x
EV / Sales 2022 2,27x
Nbr of Employees 44 500
Free-Float 60,6%
More Financials
Company
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (95.8%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (4.3%).  
Sector
Healthcare Facilities & Services
Calendar
03/11 | 09:00amInvestor Day
More about the company
Notations Surperformance© of Quest Diagnostics
Trading Rating : Investor Rating :
More Ratings
All news about QUEST DIAGNOSTICS
02/24QUEST DIAGNOSTICS : Offers Blood Test for COVID-19 Antibodies
MT
02/24QUEST DIAGNOSTICS : Introduces New COVID-19 Semi-quantitative Serology Test Serv..
PR
02/23QUEST DIAGNOSTICS INC : Change in Directors or Principal Officers, Regulation FD..
AQ
02/23QUEST DIAGNOSTICS : Announces Board Leadership Changes
PR
02/23QUEST DIAGNOSTICS : GRAIL and Quest Diagnostics Announce Collaboration to Suppor..
BU
02/23QUOTIENT : Names CEO
MT
02/23QUEST DIAGNOSTICS INC : Change in Directors or Principal Officers, Financial Sta..
AQ
02/22QUEST DIAGNOSTICS : Management's Discussion and Analysis of Financial Condition ..
AQ
02/16QUEST DIAGNOSTICS : To Speak At Citi's 2021 Healthcare Services, Medtech, Tools ..
PR
02/16QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
02/16QUEST DIAGNOSTICS : EmblemHealth and Quest Diagnostics Renew Long-Standing Strat..
PR
02/11QUEST DIAGNOSTICS : Perfect Score Five Years in a Row
PU
02/09QUEST DIAGNOSTICS : to Host Virtual Investor Day On March 11, 2021
PR
02/04QUEST DIAGNOSTICS : Q4 Adjusted EPS Almost Triples, Revenue Rises
MT
02/04QUEST DIAGNOSTICS : Raises Dividend to $0.62 a Share from $0.56, Authorizes $1 B..
MT
More news
News in other languages on QUEST DIAGNOSTICS
2020Menge an Corona-Tests stellt USA auf die Probe
2020QUEST DIAGNOSTICS : Veröffentlichung des Halbjahresergebnisses
2020QUEST DIAGNOSTICS : publication des résultats semestriels
2020GENOMIC VISION : perte nette réduite d'un tiers en 2019
2020Les valeurs à suivre aujourd'hui à la Bourse de Paris Vendredi 22 mai 2020
More news
Analyst Recommendations on QUEST DIAGNOSTICS
More recommendations
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 139,76 $
Last Close Price 115,59 $
Spread / Highest target 36,7%
Spread / Average Target 20,9%
Spread / Lowest Target 8,14%
EPS Revisions
Managers and Directors
NameTitle
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Michael E. Prevoznik General Counsel, Senior VP-Legal & Compliance